ROCK Home  |  Past and Future Meetings
The R.O.C.K. Society

2021 Program Shell
Virtual Meeting | May 21-22, 2021
Central Time Zone

Friday, May 21
10:00 am - 10:05 am
Welcome
Dean Assimos, MD
ROCK Society President
The University of Alabama at Birmingham
10:05 am - 11:25 am
Session One: Demographics / Environment / Genetics
(Each Presentation has 10 Minutes followed by 5 Minutes of Discussion)
Moderator: Charles D. Scales, Jr.

The Risk of a Symptomatic Kidney Stone During and After Pregnancy
Charat Thongprayoon

Evidence For a Role of the Renal Microbiome in the Onset of Urinary Stone Disease
Jose Agudelo

Initial Understanding of Health Literacy on Nephrolithiasis Outcomes
Naren Nimmagadda

Racial Differences in Kidney Stone Composition
Joseph J. Crivelli

Risk Stratification in Pediatric Nephrolithiasis: A Multi-Institutional Analysis of Subsequent Stone Events
Jonathan S. Ellison
11:25 am - 12:25 pm
Session Two: Demographics / Environment / Genetics
(Each Presentation has 10 Minutes followed by 5 Minutes of Discussion)
Moderator: Gregory E. Tasian

The Impact of Heat on Kidney Stone Presentations in South Carolina Under Two Climate Scenarios
Jason Kaufman

Kidney Stone Disease Prevalence From Administrative Coding Compared to Self-Report: A Report From the All of US Research Program Data
Connor M. Forbes

Osteoporosis, Fractures, and Bone Mineral Density Screening In Veterans with Kidney Stone Disease
Alan Pao

Genetics of Rare And Common Urinary Stones
Peter C. Harris
12:25 pm - 12:50 pm
BREAK
12:50 pm - 2:20 pm
Session Three: 24 Hour Urine Studies
(Each Presentation has 10 Minutes followed by 5 Minutes of Discussion)
Moderator: Anna Zisman

Assessing 24-Hour Urinary Excretion of Lithogenic Factors From Spot Urine Samples (30)
Eric N. Taylor

Effect of SGLT-2 Inhibitors on 24-Hour Urine Parameters in Stone Formers (47)
Vishnu Ganesan

Omeprazole Lowers 24-Hour Urinary Magnesium Excretion in Patients with a History of Urolithiasis (19)
Kristina L. Penniston

Use of Proton Pump Inhibitors and Risk of Nephrolithiasis: A Population and 24h Urine Analysis (28)
Wilson Sui

Association of Urine Findings with Metabolic Syndrome Traits in Patients with Known Nephrolithiasis (31)
Kevan M. Sternberg

What Defines an "Adequate" 24-hour Urine Collection? (29)
Naim M. Maalouf
2:20 pm - 2:50 pm
Industry Symposium: Supported by Alnylam
(20 Minute Presentation, Followed by 10 Minutes of Q+A)
Under to Stone: Genetics to Uncover Rare Kidney Stone Disease
Dr. Kyle Wood, Assistant Professor
University of Alabama Birmingham, Birmingham, AL
2:50 pm - 3:20 pm
BREAK
3:20 pm - 4:50 pm
Session Four: Experimental Technology/Imaging
(Each Presentation has 10 Minutes followed by 5 Minutes of Discussion)
Moderator: Jodi Antonelli

Transcutaneous Acoustic Manipulation of Objects in the Urinary Tract
Mohamed A. Ghanem

qSAS: A Quantitative Stone Analysis Software for Clinical and Research CT Imaging Studies
Andrea Ferrero

Automated Machine Learning Segmentation and Measurement of Urinary Stones on CT Scan
Rilwan Babajide

Design and Adaptation of Burst Wave Lithotripsy to Treat Small Ureteroliths in Pet Cats
Adam D. Maxwell

Flat Panel Detector C-Arms Associated with Lower Radiation Exposure in Ureteroscopy, Superior Images
Michael P. Kurtz

Not Every Low-Dose is Low-Dose: Impact of Revising Low-Dose CT Protocol on Mean Effective Radiation
Claudie Deyirmendjian
4:50 pm - 5:20 pm
Session Five: Basic Science Veterinary
(Each Presentation has 10 Minutes followed by 5 Minutes of Discussion)
Moderator: Eva Furrow

Arachidonic Acid Metabolism Genes are associated with Hypercalciuria, Calcium Oxalate Stones in Dogs
Lauren A. Baker

Characterization of the Urinary Microbiome in a Canine Model of Calcium Oxalate Urolithiasis
Emily Coffey
5:20 pm - 5:35 pm
Presidential Award Presentation
5:35 pm – 6:20 pm
Special Interest Groups

Developing a Patient-Prioritized Research Agenda for Comparative Trials In Children and Adults over the Lifespan of kidney stones: a PRACTICAL approach
Hosted by Jonathan Ellison, MD, Assistant Professor, Pediatric Urology at Children’s Hospital of Wisconsin & Medical College of Wisconsin; and Gregory Tasian, MD, MSc, MSCE, Associate Professor, Surgery and Epidemiology, University of Pennsylvania Perelman School of Medicine & The Children’s Hospital of Philadelphia

Building Interdisciplinary Research CollaborationsiIn Urolithisis to Address Critical Knowledge Gaps and Advance The Clinical Care of Patients Who Form Kidney Stones
Hosted by Kristina Penniston, PhD, RDN, FAND, Senior Scientist, Department of Urology, University of Wisconsin School of Medicine and Public Health

The Role of the Urinary Tract Microbiome in Urolithiasis: Is There One? How Should It Be Studied?
Hosted by Dirk Lange, PhD, Associate Professor, Department of Urologic Sciences, Faculty of Medicine, The University of British Columbia; and Aaron Miller, PhD, Assistant Staff Scientist,
6:20 pm - 7:00 pm
Zoom Networking Reception
Saturday, May 22
9:00 am - 9:05 am
Welcome Back
Dean Assimos, MD
ROCK Society President
The University of Alabama at Birmingham
9:05 am - 10:40 am
Session Six: Clinical Studies
(Each Presentation has 10 Minutes followed by 5 Minutes of Discussion)
Moderator: Kelly A. Healy

SKOPE - Study of Ketorolac vs Opioid for Pain after Endoscopy
Sri Sivalingam

Predictors of Cost Effectiveness of Ureteroscopic Laser Lithotripsy in A Large Multi-Hospital System
Michael S. Borofsky

Timing of Ureteral Stent Removal After Ureteroscopy on Stent-Related Symptoms - A Validated Questionnaire
Daniel Heidenberg

Impact of an Acute Care Urology Service on Timeliness and Quality of Care for Urolithiasis
Ezra J. Margolin

Insights from the STENTS Nested Qualitative Cohort: A Urinary Stone Disease Research Network Study
Jonathan D. Harper

Predictors Of Index Percutaneous Nephrolithotomy Care Setting and Impact on Perioperative Outcomes a
David F. Friedlander
10:40 am - 11:40 am
Session Seven: Clinical Studies
(Each Presentation has 10 Minutes followed by 5 Minutes of Discussion)
Moderator: Michael E. Lipkin

Developing a Patient-Centered Stone Surgery Report
Kevin Koo

Development of a New Canadian Endourology Group Stent Symptom Score (CEGSSS)
Naeem Bhojani

Examining Outcomes of Totally Tubeless Percutaneous Nephrolithotomy
Patrick Whelan

Benchtop Evaluation of Miniature Percutaneous Nephrolithitomy Lithotrites
Christian Tabob
11:40 am - 12:10 pm
BREAK
12:10 pm - 1:25 pm
Session Eight: Clinical Studies
(Each Presentation has 10 Minutes followed by 5 Minutes of Discussion)
Moderator: Vernon M. Pais, Jr

Dusting Efficiency of the Moses Pulse 120H 2.0 Laser System: An In vitro Assessment
Christopher Kim

The Social Impact of Surgery for Nephrolithiasis
Amanda E. Jones

Utility of Stone Antibiogram in Peri Operative Antibiotic for PCNL
Johann P. Ingimarsson

A Benchtop Comparison of Different Pulse Modulation Modes for Ho:YAG Laser Lithotripsy Ablation
Russell S. Terry

Ambulatory Percutaneous Nephrolithotomy: The Next Step in Surgical Evolution
Seth K. Bechis
1:25 pm - 1:55 pm
Industry Symposium: Supported by Dicerna Pharmaceuticals, Inc.
Updates in Primary Hyperoxaluria Symposim
Bernd Hoppe, MD-Head, Global Medical Affairs
Kerry Russell-VP, Late Stage Clinical Development
1:55 pm - 3:10 pm
Session Nine: Basic Science
(Each Presentation has 10 Minutes followed by 5 Minutes of Discussion)
Moderator: Kristin Bergsland

Molecular Mapping of the Stone Forming Papilla Using Spatial Transcriptomics
Tarek M. Ashkar (El-Achkar)

Oxalate Alters Macrophage Cellular Bioenergetics, Redox Homeostasis, Immune Response, and Antibacterial Response
Tanecia Mitchell

Chloroquine Attenuates Hyperoxaluria-Induced Renal Injury and CaOx Depositions
Xiaolu Duan

Isn't Pyrophosphate a Kidney Stone Inhibitor?
John R. Asplin

Factors Controlling Protein Incorporation in Calcium Oxalate Stone Matrix
Jeffrey A. Wesson
3:10 pm - 3:30 pm
BREAK
3:30 pm - 5:15 pm
Session Ten: Stone Prevention
(Each Presentation has 10 Minutes followed by 5 Minutes of Discussion)
Moderator: David S. Goldfarb

Can Smart Technology Improve Adherence to Fluid Management and Urine Output in Kidney Stone Patients
Henry C. Wright

Sodium Abnormality Linked to Diet (SALTD): Impact of Food Preparation on Urinary Values in Stone Patients
David Schulsinger

Prevention of Urinary Stones with Hydration (PUSH): Challenges and Opportunities from COVID-19
Gregory E. Tasian

Factors Reducing Calcium Oxalate Stone Risk in Patients with Bowel Disease
Megan O. Prochaska

Selective Vs Empiric Pharmacologic Therapy for Kidney Stone Prevention in a Privately Insured Population
Ryan S. Hsi

Effect of a High Citrate Beverage on Urine Chemistry In Kidney Stone Formers
Lama Nazzal

The Impact of Phone Counseling on Urinary Stone Prevention
Mira T. Keddis
5:15 pm - 5:45 pm
Business Meeting
* Business Meeting for members only
5:45 pm
Adjourn